Home/Filings/4/0001209191-17-039812
4//SEC Filing

TETRAPHASE PHARMACEUTICALS INC 4

Accession 0001209191-17-039812

CIK 0001373707operating

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:07 PM ET

Size

6.9 KB

Accession

0001209191-17-039812

Insider Transaction Report

Form 4
Period: 2017-06-13
Horn Patrick Taylor
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-06-13$2.03/sh+10,000$20,30010,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2017-06-1310,00047,689 total
    Exercise: $2.03Exp: 2021-01-02Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]This option is fully vested.

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001373707

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:07 PM ET
Size
6.9 KB